NeuroPace | 10-Q: Q2 2024 Earnings Report
NeuroPace | 8-K: NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Fischer Frank M
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Kumar Rakhi
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Andrade Lisa
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Ryan Renee
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Geiger Uri
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director LACOB JOSEPH
NeuroPace | 8-K: Current report
NeuroPace | 10-Q: Q1 2024 Earnings Report
NeuroPace | 8-K: NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | ARS: Annual Report to Security Holders
NeuroPace | DEFA14A: Others
NeuroPace | DEF 14A: Definitive information statements
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data
No Data